Does short-term octreotide treatment induce apoptosis in human pancreatic cancer xenografts?
The results suggest that low doses of octreotide induce apoptosis in human pancreatic cancer xenografts after a short-term treatment.
CVVHDF during RxP is feasible and well tolerated but ioversol removal is modest. This fact together with the high incidence of renal function impairment, the complexity of the procedure and its intrinsic risks, and the large amount of resources needed discourage the routine use of CVVHDF as a prophylactic tool to avoid CM nephropathy.